LBPHLongboard Pharmaceuticals, ...

Nasdaq longboardpharma.com


$ 22.07 $ 1.45 (7.01 %)    

Tuesday, 07-May-2024 15:59:56 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 22.045
$ 21.09
$ 22.01 x 200
$ 22.08 x 200
$ 20.47 - $ 22.41
$ 3.60 - $ 28.15
316,024
na
778.67M
$ 0.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-longboard-pharmaceuticals-maintains-60-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and maintains...

 cantor-fitzgerald-reiterates-overweight-on-longboard-pharmaceuticals-maintains-60-price-target

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...

 wedbush-maintains-outperform-on-longboard-pharmaceuticals-raises-price-target-to-34

Wedbush analyst Laura Chico maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and raises the price target ...

 longboard-pharmaceuticals-q1-eps-042-beats-052-estimate

Longboard Pharmaceuticals (NASDAQ:LBPH) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimat...

 baird-initiates-coverage-on-longboard-pharmaceuticals-with-outperform-rating-announces-price-target-of-36

Baird analyst Joel Beatty initiates coverage on Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform rating and announc...

 hc-wainwright--co-reiterates-buy-on-longboard-pharmaceuticals-maintains-60-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and maintains...

 cantor-fitzgerald-reiterates-overweight-on-longboard-pharmaceuticals-maintains-60-price-target

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...

 longboard-pharmaceuticals-to-present-data-from-pacific-study-at-aan-annual-meeting-on-april-15

PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annua...

 hc-wainwright--co-maintains-buy-on-longboard-pharmaceuticals-maintains-60-price-target

HC Wainwright & Co. analyst Patrick Trucchio maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and maintains ...

 cantor-fitzgerald-reiterates-overweight-on-longboard-pharmaceuticals-maintains-60-price-target

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...

 wedbush-reiterates-outperform-on-longboard-pharmaceuticals-maintains-32-price-target

Wedbush analyst Laura Chico reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and maintains $32 price tar...

 citigroup-initiates-coverage-on-longboard-pharmaceuticals-with-buy-rating-announces-price-target-of-40

Citigroup analyst David Hoang initiates coverage on Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy rating and announces ...

Core News & Articles

-SEC Filing

 why-intel-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth q...

 cantor-fitzgerald-maintains-overweight-on-longboard-pharmaceuticals-raises-price-target-to-60

Cantor Fitzgerald analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and raises the p...

 hc-wainwright--co-maintains-buy-on-longboard-pharmaceuticals-raises-price-target-to-60

HC Wainwright & Co. analyst Patrick Trucchio maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and raises the...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION